The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics, Inc. | COM | 00461U105 | 5,529 | 748,132 | SH | SOLE | 748,132 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 9,452 | 261,823 | SH | SOLE | 261,823 | 0 | 0 | ||
Arbutus Biopharma Corporation | COM | 03879J100 | 6,060 | 1,582,275 | SH | SOLE | 1,582,275 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 15,376 | 245,424 | SH | SOLE | 245,424 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 31,651 | 855,900 | SH | SOLE | 855,900 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 20,708 | 2,631,258 | SH | SOLE | 2,631,258 | 0 | 0 | ||
Cytokinetics Incorporated | COM NEW | 23282W605 | 1,107 | 175,148 | SH | SOLE | 175,148 | 0 | 0 | ||
Eidos Therapeutics, Inc. | COM | 28249H104 | 5,941 | 431,781 | SH | SOLE | 431,781 | 0 | 0 | ||
Immunomedics, Inc. | COM | 452907108 | 17,201 | 1,205,363 | SH | SOLE | 1,205,363 | 0 | 0 | ||
Insmed Incorporated | COM | 457669307 | 25,941 | 1,977,236 | SH | SOLE | 1,977,236 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | Class A Common | G5269C101 | 1,796 | 63,922 | SH | SOLE | 63,922 | 0 | 0 | ||
Myokardia, Inc. | COM | 62857M105 | 23,776 | 486,624 | SH | SOLE | 486,624 | 0 | 0 | ||
OptiNose, Inc. | COM | 68404V100 | 10,593 | 1,708,545 | SH | SOLE | 1,708,545 | 0 | 0 | ||
Orchard Therapeutics PLC | ADS | 68570P101 | 10,513 | 668,361 | SH | SOLE | 668,361 | 0 | 0 | ||
Portola Pharmaceuticals, Inc. | COM | 737010108 | 4,880 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Replimune Group, Inc. | COM | 76029N106 | 12,297 | 1,229,656 | SH | SOLE | 1,229,656 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 10,752 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
SI-BONE, Inc. | COM | 825704109 | 4,295 | 205,621 | SH | SOLE | 205,621 | 0 | 0 |